CONCLUSION
Patients with ICM presenting with VT undergoing first-line VT ablation
have a significant lower rate of appropriate ICD therapies without a
mortality difference compared to patients receiving an initial approach
based on medical therapy. The beneficial effect in improved
survival-free from VT/VF and appropriate ICD therapies was seen only in
patients with moderately depressed LVEF. First-line VT ablation should
be considered the therapeutic approach of choice in this selected group
of patients to improve clinical outcomes.